Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Email me when HR 9418 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 9418. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
Rep. Nanette Diaz Barragán introduced the Access to Innovative Treatments Act of 2026 to address how patients obtain new medical therapies. The measure has been referred to the Ways and Means Committee and the Energy and Commerce Committee for further consideration.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 9418
3 free questions a day, no accountSponsors
- Rep. Barragán, Nanette Diaz [D-CA-44] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 9418 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 9418 freeOr ask your AI assistant about HR 9418 directly:
Add to Claude, ChatGPT or Cursor